Lupus Science & Medicine

1. Lupus Sci Med17 Aug 2026

   Subclinical ocular microvascular involvement in primary antiphospholipid syndrome and antiphospholipid antibody carriers

   Cross-sectional studyLupus & APS

2. Lupus Sci Med14 Aug 2026

   Maternal systemic autoimmune rheumatic diseases and childhood mental disorders: a nationwide cohort study

   Cohort studyAcross diseases

3. Lupus Sci Med12 Aug 2026

   The lupus damage index revision program: Results from the item generation and reduction phases

   Guideline or statementLupus & APS

4. Lupus Sci Med11 Aug 2026

   Immune thrombocytopenia is rare in patients with antiphospholipid syndrome without systemic lupus erythematosus: insights from a series of 351 patients

   Cohort studyLupus & APS

5. Lupus Sci Med11 Aug 2026

   Free mycophenolic acid exposure for therapeutic drug monitoring in paediatric lupus nephritis: associations with treatment response and haematologic toxicity

   Cohort studyPediatric

6. Lupus Sci Med10 Aug 2026

   CD163: a potential biomarker for lupus nephritis activity

   Cross-sectional studyLupus & APS

7. Lupus Sci Med6 Aug 2026

   Occurrence of venous thromboembolism in SLE: findings from a nationwide cohort and a clinical cohort in Sweden

   Cohort studyLupus & APS

8. Lupus Sci Med6 Aug 2026

   Diagnostic value of cerebrospinal fluid antisuprabasin antibody in neuropsychiatric systemic lupus erythematosus

   Diagnostic or prognostic studyLupus & APS

9. Lupus Sci Med5 Aug 2026

   High disease activity persists in adults with childhood-onset lupus

   Cohort studyLupus & APS

10. Lupus Sci Med3 Aug 2026

    Peripheral blood CD19+B cell proportion at baseline predicts early complete response to belimumab treatment in patients with refractory lupus nephritis

    Cohort studyLupus & APS

11. Lupus Sci Med31 Jul 2026

    Role of repeat kidney biopsy after 6 months of treatment in proliferative lupus nephritis

    Cohort studyLupus & APS

12. Lupus Sci Med28 Jul 2026

    Lupus Nexus: developing a prospective registry, biorepository and data exchange platform to foster global collaborations, accelerate research innovation and advance precision medicine in lupus

    Cohort studyLupus & APS

13. Lupus Sci Med27 Jul 2026

    Targeting type I interferon in lupus autoimmune haemolytic anaemia: first report with anifrolumab

    Cohort studyLupus & APS

14. Lupus Sci Med27 Jul 2026

    Risk of falls, recurrent falls and osteoporotic fractures in SLE patients with comorbid fibromyalgia: a propensity score-matched cohort study using the TriNetX Network

    Cohort studyLupus & APS

15. Lupus Sci Med23 Jul 2026

    Circulating kidney injury molecule-1 as a prognostic biomarker for long-term renal outcomes in lupus nephritis: a retrospective cohort study

    Cohort studyLupus & APS

16. Lupus Sci Med22 Jul 2026

    Glucocorticoid exposure and social support deficits as longitudinal predictors of long-term neuropsychiatric damage in SLE: insights from the LUMINA cohort (LXXXIII)

    Cohort studyLupus & APS

17. Lupus Sci Med21 Jul 2026

    Harnessing AI and social media to understand real-world patient experiences in SLE

    Cross-sectional studyLupus & APS

18. Lupus Sci Med20 Jul 2026

    Prevalence and clinical associations of cerebral atrophy in systemic lupus erythematosus

    Cross-sectional studyLupus & APS

19. Lupus Sci Med20 Jul 2026

    Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity

    Cohort studyLupus & APS

20. Lupus Sci Med16 Jul 2026

    Real-world treatment patterns and outcomes in moderate-to-severe SLE: findings from the Spanish SPOCS cohort

    Cohort studyLupus & APS

21. Lupus Sci Med15 Jul 2026

    Integrated immune profiling identifies a coordinated T-cell activation and inflammatory signature in SLE

    Mechanistic studyLupus & APS

22. Lupus Sci Med13 Jul 2026

    International development of a lupus-specific instrument to assess cognitive symptoms in patients with SLE: Lupus Brain Fog Severity Scale (LBFSS) study

    Diagnostic or prognostic studyLupus & APS

23. Lupus Sci Med9 Jul 2026

    Real-world experience with personalised belimumab spacing in sustained SLE remission: a multicentre study

    Cohort studyLupus & APS

24. Lupus Sci Med7 Jul 2026

    Upadacitinib enhances platelet procoagulant responses in a subset of healthy individuals and patients with SLE: a pilot study

    Mechanistic studyLupus & APS

25. Lupus Sci Med7 Jul 2026

    Qualitative interview study in patients with SLE to assess patient perception of fatigue and skin-related symptoms

    Research articleLupus & APS

26. Lupus Sci Med2 Jul 2026

    Remission and low disease activity state in childhood-onset systemic lupus erythematosus: differential impact on damage accrual in a Latin American cohort (GLADEL)

    Cohort studyPediatric

27. Lupus Sci Med2 Jul 2026

    Development and validation of a lectin-based assay for detection of IgG Fc glycosylation as a biomarker in lupus nephritis

    Diagnostic or prognostic studyLupus & APS

28. Lupus Sci Med1 Jul 2026

    Anti-endothelin receptor A autoantibodies associate with immunovascular risk and activate endothelial signalling in SLE

    Cross-sectional studyLupus & APS

29. Lupus Sci Med1 Jul 2026

    Quantitative mapping of prefrontal oxygenation dysfunction and neuropsychiatric symptoms in patients with systemic lupus erythematosus: a multichannel functional near-infrared spectroscopy study

    Cross-sectional studyLupus & APS

30. Lupus Sci Med30 Jun 2026

    Are RAS inhibitors necessary during intensive immunosuppression for lupus nephritis? Real-world evidence from the STAR cohort

    Cohort studyLupus & APS

31. Lupus Sci Med29 Jun 2026

    Increasing the utilisation of hydroxychloroquine blood level testing in lupus: a quality improvement project

    Research articleLupus & APS

32. Lupus Sci Med29 Jun 2026

    Antiphospholipid syndrome in the paediatric population: performance of ACR-EULAR classification criteria in a controlled cohort

    Diagnostic or prognostic studyPediatric

33. Lupus Sci Med29 Jun 2026

    Effects of exercise interventions on core health outcomes in patients with SLE: systematic review and meta-analysis

    Meta-analysisLupus & APS

34. Lupus Sci Med29 Jun 2026

    Old marker, new face: anti-RNP as a sentinel of coronary and peripheral endothelial dysfunction in systemic lupus erythematosus

    Cross-sectional studyLupus & APS

35. Lupus Sci Med28 Jun 2026

    Type I interferons enhance B cell activation and promote differentiation of double negative 2 cells in SLE

    Mechanistic studyLupus & APS

36. Lupus Sci Med25 Jun 2026

    Development of a LASSO-based machine learning model for relapse prediction in lupus nephritis

    Cohort studyLupus & APS

37. Lupus Sci Med25 Jun 2026

    Influence of sex and systemic lupus erythematosus disease status on cerebral cortex structure

    Cross-sectional studyLupus & APS

38. Lupus Sci Med24 Jun 2026

    Prognostic value of baseline clinical features in SLE: a cluster analysis

    Cohort studyLupus & APS

39. Lupus Sci Med23 Jun 2026

    Genetic determinants of childhood onset systemic lupus erythematosus

    Research articlePediatric

40. Lupus Sci Med18 Jun 2026

    Belimumab as a possible treatment for SLE-associated pulmonary arterial hypertension: the experience from a single centre

    Cohort studyLupus & APS

All 423 Briefs in ExploreShowing Briefs 41–80 of 423, newest first